Subscribe
Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

JAMA Editor’s Summary

Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

Editor's Audio Summary by Mary McGrae McDermott, MD, Senior Editor, the Journal of the American Medical Association, for the November 06, 2013 issue
November 5, 2013
ADVERTISEMENT
Wise-Formerly Transferwise

Trial of colloids vs crystalloids for hypovolemic shock, testosterone and CV mortality, review of malignant gliomas, and more.

Editor’s Audio Summary by Mary McGrae McDermott, MD, Senior Editor, the Journal of the American Medical Association, for the November 06, 2013 issue

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.